OneWelbeck is London’s most accessible and advanced destination for outstanding healthcare. We provide unrivalled preventative diagnostics and treatment in our state-of-the-art facilities, right in the heart of the capital. Combining advanced technologies with the most recent medical developments, OneWelbeck has developed a unique prevention programme that focuses on early disease detection and proactive health management to help patients lead longer, healthier lives.
Our Health Assessment and Longevity service is an integrated screening service that utilises the expertise of over 300 clinician partners, the latest diagnostic modalities and personalised management plans to provide unparalleled preventive healthcare under one roof.
Health promotion and disease prevention are not just cost-effective, but also mean that one benefits from living a healthier life. Many health conditions can be almost entirely prevented or cured with effective screening and appropriate management. Other conditions, including certain cancers, also have considerably better outcomes and survival rates when identified and treated at an early stage.
National guidelines, up-to-date clinical evidence and collaborative input from our medical directors across 16 specialities have been paramount in the development of our Health Assessment and Longevity service. By offering all tests within a single facility, and a flexible schedule suited to patient availability, we not only ensure appropriate tests are requested but also arrange prompt follow-up appointments should the need arise.
Each assessment is comprised of a personalised programme of investigations, tailored to an individual’s health requirements and risk profile, which is planned and developed after an in-depth consultation with a screening doctor.
Our unique ability to provide access to a diverse team of world-leading medical specialists and the availability of comprehensive testing all under the same roof, is what truly sets us apart. We are also proud of our ability to expedite and accommodate urgent specialist reviews on the same day as the assessment, if required.
Recognising that a day of transitioning between tests can be lengthy and tiresome, our Health Assessment and Longevity team has taken additional measures to allow for the most comfortable experience. Each individual is allocated a personal relaxation pod in our executive lounge area, and a dedicated client liaison manager who facilitates their testing itinerary and chaperones them throughout the building, ensuring they are in the right place and time for each of their scheduled tests.
Individual test results are consolidated by the screening doctor into a comprehensive health report. During a follow-up consultation, the screening doctor will go through the findings of the report with each individual and customise an action plan.
Navigating the various available health packages can be overwhelming, so an initial, comprehensive 60-minute consultation with our experienced screening doctors, including physical and psychological assessment, can be arranged. This ensures a holistic approach to health and wellness and is an excellent starting point for patients. Following the initial consultation, the Health Assessment and Longevity doctor will develop a plan with the patient to suit their medical needs and achieve optimal health management for their journey.
Genetic testing: Whole Genome Sequencing (WGS) analyses a patient’s entire genome to identify their potential risk of developing certain conditions and diseases. To effectively and sensitively manage the screening, we have partnered with some of the world's leading genetic experts, who provide counsel prior to testing, discuss positive results with patients, review findings as a multidisciplinary team, provide ongoing support and referral channels, and deliver precise and personalised management at an early stage, if required.
GlycanAge: the innovative GlycanAge test allows our Health Assessment and Longevity team to identify whether a patient is at an increased risk of certain health conditions. By measuring chronic inflammation in your system, the test determines biological age, which is directly related to lifestyle. With the results, our team can pinpoint inflammation-causing factors and help patients address and reduce inflammation through often simple lifestyle changes.
GutID microbiome testing: maintaining a healthy gut and promoting overall health requires a balanced composition of microbiome. An imbalance can result in chronic inflammation, a driver of symptoms such as bloating, fatigue and inflammation, and conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Chronic systemic diseases – such as obesity, diabetes and liver disease – can also arise. Utilising the GutID test and working with leading specialists, we can identify imbalances and improve the biome to restore balance, improve symptoms and reduce the risk of disease development.
Caristo CariHeart: using AI technology, Caristo CaRi-Heart analysis measures the amount of inflammation in the coronary arteries and generates an individualised risk score to aid the diagnosis and management of coronary artery disease. By uncovering hidden inflammation, this test allows us to implement preventative management and treatment plans to lower a patient’s risk of heart attack and other cardiac diseases.
Brain Key: Beginning with a high-resolution 3D brain MRI scan, Brain Key provides an AI-driven analysis of a patient’s brain health. The test analyses key biomarkers and brain regions to assess brain health at a biological level to provide a comprehensive assessment of brain age, and also identifies early signs of brain changes that can indicate dementia risk.
TruCheck Intelli: early detection of cancer is critical for better treatment outcomes. Using TruCheck Intelli – a simple, but revolutionary, blood test – we can detect over 70 types of solid organ cancers in patients without symptoms. Currently, the test can detect early signs of cancer in at least 88% of cases, allowing us to provide early treatment to ensure patients achieve the best possible outcomes.
Cardiopulmonary exercise test (CPET): this non-invasive test provides a score known as VO2 max, which is currently the single best predictor of longevity. As well as assessing a patient’s peak oxygen consumption during exercise to give us a global measure of their current fitness status, the test can also be helpful in the diagnosis and subsequent treatment of conditions such as heart failure and lung diseases.
Sunrise sleep study: sleep is the most important element for health and longevity, but it can be affected by many factors. Utilising the Sunrise sleep test as an initial screening tool, our world-leading respiratory consultants, who specialise in sleep, can detect underlying sleep disorders that can lead to an array of health complications, including heart disease and stroke. The simple test measures jaw movement during sleep and collects the data into a report that is then interpreted by our sleep specialists, who will devise a personalised treatment plan, if necessary.
To learn more about OneWelbeck's services or to refer a patient,
please call +44 (0)20 3653 2000 or visit onewelbeck.com
